Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies
CX-5461 针对富含 DNA 修复缺陷的晚期实体瘤患者的 I 期 CCTG IND.231 试验结果
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-31199-2
John Hilton #, Karen Gelmon #, Philippe L Bedard, Dongsheng Tu, Hong Xu, Anna V Tinker, Rachel Goodwin, Scott A Laurie, Derek Jonker, Aaron R Hansen, Zachary W Veitch, Daniel J Renouf, Linda Hagerman, Hongbo Lui, Bingshu Chen, Deb Kellar, Irene Li, Sung-Eun Lee, Takako Kono, Brian Y C Cheng, Damian